Munawwar Hussain

Researcher

University of Arkansas for Medical Sciences

faculty

6 h-index 13 pubs 90 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

Munawwar Hussain's research focuses on multiple myeloma, including its clinical outcomes and treatment strategies. He has investigated the feasibility of outpatient stem cell transplantation for patients with multiple myeloma and examined risk factors predictive of hospital admission following the procedure. His work also addresses specific therapeutic approaches, such as BCMA-directed CAR-T therapy and the use of bone-modifying agents. Additionally, Hussain has explored the corneal toxicity associated with belantamab mafodotin and the role of tandem autologous stem cell transplantation in managing persistent minimal residual disease. His recent publication in 2024 considers the stem cell origin of cancer and its implications for drug and therapy development beyond immunotherapy. Hussain has a citation count of 90 and an h-index of 6 across 13 publications. He frequently collaborates with researchers at the University of Arkansas for Medical Sciences, including Nishanth Thalambedu, Jaskirat Sethi, Sravani Gundarlapalli, and Samer Al Hadidi.

Metrics

  • h-index: 6
  • Publications: 13
  • Citations: 90

Selected Publications

  • Stem Cell Origin of Cancer: Clinical Implications beyond Immunotherapy for Drug versus Therapy Development in Cancer Care (2024) DOI
  • Differential Diagnosis and Therapeutic Advances in Multiple Myeloma: A Review Article (2023) DOI
  • Sixth Nerve Palsy From Multiple Myeloma in Central Nervous System: Case Series and Review of Current Literature (2023) DOI
  • Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy (2022) DOI
  • Clinical Outcome of Patients with Relapsed Refractory Multiple Myeloma Listed for BCMA Directed Commercial CAR T Therapy (2022) DOI
  • Parameters Influencing Count Recovery Post Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (2022) DOI
  • Immunogenicity of Covid-19 Vaccine Among Multiple Myeloma Patients Post Autologous Stem Cell Transplant (2022) DOI
  • MM-531 Case Control Study of Outcomes of Autologous Stem Cell Transplantation in Jehovah's Witness Multiple Myeloma Patients (2022) DOI
  • Poster: MM-531 Case Control Study of Outcomes of Autologous Stem Cell Transplantation in Jehovah's Witness Multiple Myeloma Patients (2022) DOI
  • Corneal toxicity with belantamab mafodotin: Multi‐institutional <scp>real‐life</scp> experience (2022) DOI
  • The use of bone-modifying agents in multiple myeloma (2022) DOI
  • Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission (2022) DOI
  • Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma (2022) DOI

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics